Page 27 - Ciences News Today

GRO Biosciences Inc. ("GRObio"), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics, presented successful proof of concept results in two pre-clinical...

Alafair Biosciences has been selected to exhibit VersaWrap, a class II medical device, at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation's largest provider-driven healthcare performance improvement company, will hold the...

SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of the central nervous system (CNS) and oncology, and its U.S. R&D subsidiary, Proteovant Therapeutics, today announced...

Cloudflare, Inc. , the leading connectivity cloud company, today announced a partnership with Meta to make the Llama 2 open source large language model (LLM) available to developers building AI applications on Cloudflare's developer platform,...

Timed to coincide with the Utah Jazz's 50th season celebration, SEG Media today launched Jazz+. This Utah Jazz-branded, direct-to-consumer...

Epiq announced today the availability of new AI and analytics services and solutions for law firms and corporate legal departments, providing the intelligence to manage and deliver the legal services outcomes they desire. Epiq's offerings include...

Connectbase, The Industry Cloud for Connectivity, announces an expanded partnership with Horizon, a long-time customer of The Connected World platform. Horizon, a facilities-based fiber-optic broadband service provider operating in several states in...

In recognition of National Drive Electric Week (Sept. 22 - Oct. 1, 2023), Pacific Gas and Electric Company (PG&E) is sharing its progress to advance technology that will enable electric vehicles (EV) to serve as virtual power sources to help offset...

PingSafe, the only CNAPP platform powered by attacker intelligence, today announced a strategic partnership with Human Managed, providing data-driven and evidence-based security findings to improve the security posture of their extended customer...

Kallyope, Inc., a clinical stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with high unmet need, today announced the initiation of their Phase 2 trial evaluating K-757 and K-833, new oral...